Shanghai General Healthy Information and Technology Co (605186) Fair Value & Analysis

Healthcare · CN · Market cap 4.7B CNY

Analysis

Shanghai General Healthy Information and Technology Co (605186) currently trades at ¥34.08, while our model-based Fair Value estimate is ¥5.55 — implying the stock looks roughly 83.7% overvalued today. We read business quality at 87/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Shanghai General Healthy Information and Technology Co., Ltd. provides pharmaceutical logistics automation, information technology, and intelligent and mobile medical solutions in China. The company's products include the Smart Pharmacy Project, an intelligent drug management system that combines software and hardware; intelligent static distribution center project, an intelligent intravenous drug configuration and management system; and Intelligent Drug Consumables Management Project, a management system for drug consumables, including poisonous hemp drugs and high-value medical consumables. The company was founded in 2014 and is based in Shanghai, China.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.